Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.
about
Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous systemTargeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brainRegulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice.Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.
P2860
Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@ast
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@en
type
label
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@ast
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@en
prefLabel
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@ast
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@en
P2860
P356
P1476
Activating PKC-β1 at the blood ...... ores drug delivery to the CNS.
@en
P2093
Brian T Hawkins
Xueqian Wang
P2860
P304
P356
10.1038/JCBFM.2011.44
P577
2011-04-13T00:00:00Z